TickerFactsScreenerDevelopers

BIOGEN INC. (BIIB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2007: $1.02B2008: $1.56B2009: $1.07B2010: $1.62B2011: $1.73B2012: $1.88B2013: $2.35B2014: $2.94B2015: $3.92B2016: $4.59B2017: $4.55B2018: $6.19B2019: $7.08B2020: $4.23B2021: $3.64B2022: $1.38B2023: $1.55B2024: $2.88B2025: $2.20B$2.20B
2007Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$2.20B-23.3%
2024$2.88B+85.9%
2023$1.55B+11.8%
2022$1.38B-62.0%
2021$3.64B-13.9%
2020$4.23B-40.2%
2019$7.08B+14.4%
2018$6.19B+36.0%
2017$4.55B-0.8%
2016$4.59B+17.0%
2015$3.92B+33.2%
2014$2.94B+25.5%
2013$2.35B+24.7%
2012$1.88B+8.8%
2011$1.73B+6.3%
2010$1.62B+51.1%
2009$1.07B-31.2%
2008$1.56B+53.4%
2007$1.02B—